To evaluate the expression correlation of CD90 and SHH/Gli signalling in liver cancer, the expression of CD90 and major components of this pathway were first determined in different liver cancer cell lines (Figure 1 and Figure S1). This evidence concerns the gene THY1 and liver cancer.